Aberdeen Group plc decreased its position in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 2.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,682,786 shares of the company’s stock after selling 77,795 shares during the period. Procter & Gamble accounts for 0.6% of Aberdeen Group plc’s portfolio, making the stock its 19th largest position. Aberdeen Group plc owned 0.11% of Procter & Gamble worth $384,470,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC grew its position in shares of Procter & Gamble by 51.5% during the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock worth $6,717,000 after buying an additional 13,617 shares during the period. Taylor Financial Group Inc. boosted its stake in Procter & Gamble by 10.6% during the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock worth $493,000 after acquiring an additional 277 shares during the last quarter. Sivia Capital Partners LLC boosted its stake in Procter & Gamble by 19.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company’s stock worth $979,000 after acquiring an additional 1,016 shares during the last quarter. Auxano Advisors LLC grew its holdings in Procter & Gamble by 10.8% during the second quarter. Auxano Advisors LLC now owns 7,315 shares of the company’s stock valued at $1,165,000 after purchasing an additional 714 shares during the period. Finally, Schnieders Capital Management LLC. increased its stake in Procter & Gamble by 2.8% in the second quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company’s stock valued at $4,809,000 after purchasing an additional 809 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Trading Down 0.7%
Shares of NYSE:PG opened at $143.06 on Friday. The firm has a market cap of $332.46 billion, a price-to-earnings ratio of 21.19, a PEG ratio of 5.07 and a beta of 0.41. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $174.80. The company’s fifty day simple moving average is $153.71 and its 200 day simple moving average is $149.79. The company has a quick ratio of 0.51, a current ratio of 0.72 and a debt-to-equity ratio of 0.49.
Procter & Gamble Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, February 17th. Investors of record on Friday, January 23rd were given a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend was Friday, January 23rd. Procter & Gamble’s dividend payout ratio (DPR) is currently 62.67%.
Key Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Supply Chain 3.0 — P&G is rolling out a “Supply Chain 3.0” program to link real‑time demand to production, aiming to cut waste, raise efficiency and improve long‑term margins and cash flow; this is a structural margin catalyst if execution scales. Is Procter & Gamble’s Supply Chain 3.0 a Catalyst for Margin Growth? Zacks: Supply Chain 3.0
- Positive Sentiment: OLAY peptide research — New clinical-backed peptide science from OLAY could accelerate product upgrades and premiumization in skincare, supporting revenue mix and brand momentum. OLAY Peptide Research Puts New Spotlight On Procter And Gamble Valuation
- Positive Sentiment: Defensive / dividend appeal — As recession fears persist, PG’s low‑beta, dividend‑rich profile keeps it attractive to income and defensive buyers. As Recession Odds Climb, Defensive Sectors Continue to Outperform (PG) The 5 Safest Dividend Aristocrats
- Neutral Sentiment: Quarterly outlook — Analysts expect low single‑digit earnings growth for the coming quarter; execution vs. those modest expectations will drive near‑term reaction. What to Expect From Procter & Gamble’s Next Quarterly Earnings Report
- Neutral Sentiment: General analyst commentary — Various analyst notes and media pieces summarize P&G’s defensive positioning and competitive dynamics; useful context but mixed for immediate price action. Analysts Offer Insights on Consumer Goods Companies
- Negative Sentiment: TD Cowen trims target and estimates — TD Cowen cut its price target to $142 (maintained Hold) and lowered segment estimates, citing weaker pricing power; that reduction is pressuring sentiment. TD Cowen Flags Weaker Pricing Power, Trims P&G Target MarketScreener: TD Cowen Adjusts Price Target
- Negative Sentiment: Deutsche Bank cut target — Deutsche Bank lowered its target to $162 from $171 and highlighted inflation and currency headwinds as near‑term risks to margins. Deutsche Bank Highlights Inflation and Currency Headwinds for P&G
Wall Street Analyst Weigh In
A number of equities analysts have recently weighed in on PG shares. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Procter & Gamble from $171.00 to $162.00 and set a “hold” rating on the stock in a research report on Monday. JPMorgan Chase & Co. raised Procter & Gamble from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $157.00 to $165.00 in a research note on Friday, January 23rd. Dbs Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating in a report on Friday, January 23rd. Jefferies Financial Group raised Procter & Gamble from a “hold” rating to a “buy” rating and boosted their target price for the company from $156.00 to $179.00 in a research note on Tuesday, December 16th. Finally, Piper Sandler began coverage on Procter & Gamble in a report on Wednesday, January 7th. They issued a “neutral” rating and a $150.00 price target for the company. Twelve investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus target price of $167.06.
View Our Latest Research Report on PG
Insider Transactions at Procter & Gamble
In related news, Chairman Jon R. Moeller sold 162,232 shares of the firm’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $162.45, for a total value of $26,354,588.40. Following the completion of the transaction, the chairman owned 319,385 shares of the company’s stock, valued at approximately $51,884,093.25. This trade represents a 33.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Gary A. Coombe sold 36,093 shares of Procter & Gamble stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $162.33, for a total transaction of $5,858,976.69. Following the completion of the sale, the chief executive officer owned 34,994 shares in the company, valued at $5,680,576.02. The trade was a 50.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 348,618 shares of company stock worth $55,462,643. Corporate insiders own 0.20% of the company’s stock.
Procter & Gamble Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
See Also
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
